top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Valion Bio, Inc.

News headline image
Valion Bio (Nasdaq:VBIO): Oral Mucosal Entolimod Could Offer a New Needle-Free Deployment Path to Support Growing Need for Scalable Civilian Radiation Preparedness Should Nuclear Infrastructure Expand to Support Data Centers
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Announces Changes to Management and Board of Directors
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Announces Reverse Stock Split
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
News headline image
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
From Valion Bio, Inc.
Via ACCESS Newswire
Tickers VBIO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page